SPRING-2 the future of antiretroviral therapy

Lancet Infect Dis. 2013 Nov;13(11):908-9. doi: 10.1016/S1473-3099(13)70194-4. Epub 2013 Sep 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / administration & dosage*
  • HIV-1 / isolation & purification*
  • Heterocyclic Compounds, 3-Ring / administration & dosage*
  • Humans
  • Male
  • Oxazines
  • Piperazines
  • Pyridones

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir